NCT05008003

Vit D3 for Early Symptoms of COVID-19

Vit D3 Adjuvant Therapy for Early Mild Symptoms of COVID-19

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 50 (estimated)
• Sponsor: Ayub Teaching Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study is aimed to investigate the treatment vitamin D3 as complementary therapy with routine care for early mild symptoms of COVID-19 in outpatients setting.

Detailed description

There is currently no specific early-stage therapeutic treatment available for COVID-19. Vitamin D3 is a strong antioxidant, and anti-inflammatory/immunomodulatory agent. The present study is aimed to investigate the treatment benefits of vitamin D3 as add-on therapy to the routine care for early mild symptoms of COVID-19 infection in outpatients setting.

Conditions

• Covid19

Interventions

Type	Name	Description
DRUG	Standard of care	Standard of care treatment as per the hospital guidelines
DIETARY_SUPPLEMENT	Vitamin D3	A daily dose of 5000 IU vitamin D3 for 7 days.

Timeline

• Start date: 2022-09-02
• Primary completion: 2023-03-01
• Completion: 2023-04-30
• First posted: 2021-08-17
• Last updated: 2022-04-04

Locations

1 site across 1 country: Pakistan